To evaluate the efficacy of homoeopathic medicines in reducing the recurrence of otorrhea in Chronic Otitis Media

A clinical trial to evaluate the efficacy of homoeopathic medicines in reducing the recurrence of otorrhea in Chronic Otitis Media

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030832

Enrollment

Registered

2021-01-29

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H661- Chronic tubotympanic suppurative otitis media

Interventions

Intervention1: Homoeopathic medicines: Individualised homoeopathic medicines as per homoeopathic principles Intervention2: HOMOEOPATHIC MEDICINES: INDIVIDUALISED Control Intervention1: NOT APPLICABLE:

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 10-65 years of any gender. 2. Patients with persistent/recurrent otorrhoea for a period of at least 6 weeks Ã¢â?¬â?? 3 months.

Exclusion criteria

Exclusion criteria: 1. Patients with cranio facial anomalies 2. COM with complication (intra cranial complications-meningitis, otitic hydrocephalous, lateral sinus thrombosis, cavernous sinus thrombosis, intra cranial sepsis& extra cranial complications-mastoid abscess, labyrinthine fistula, labyrinthitis, facial nerve paralysis) 3. COM with cholesteatoma. 4. Known case of Diabetes mellitus. 5. Pregnant and lactating mothers. 6. Patients on antibiotic treatment within 7 days prior to screening.

Design outcomes

Primary

Measure	Time frame
1) To study the efficacy of Homoeopathic medicines in reducing the recurrence of otorrhoea in COM.Timepoint: 1 year follow up	—

Secondary

Measure	Time frame
1) To analyse the efficacy of homoeopathic medicines in reducing hearing impairment associated with COM. 2) To analyse the efficacy of homoeopathic medicines in reducing tympanic membrane perforation seen in COM. 3) To analyse the utility of homoeopathic medicines in reducing the frequency of upper respiratory tract infections (URTIÃ¢â?¬â?¢S) commonly associated with COM. 4) To analyse the quality of life (QOL) of the patients before and after the study using chronic ear survey (CES). Timepoint: 1 year follow up	—

Measure

Time frame

1) To analyse the efficacy of homoeopathic medicines in reducing hearing impairment associated with COM. 2) To analyse the efficacy of homoeopathic medicines in reducing tympanic membrane perforation seen in COM. 3) To analyse the utility of homoeopathic medicines in reducing the frequency of upper respiratory tract infections (URTIÃ¢â?¬â?¢S) commonly associated with COM. 4) To analyse the quality of life (QOL) of the patients before and after the study using chronic ear survey (CES). Timepoint: 1 year follow up

—

Countries

India

Contacts

Public ContactDR VINITHA E R

NATIONAL HOMOEOPATHY RESEARCH INSTITUTE IN MENTAL HEALTH KOTTAYAM

vinitha_sajeev@yahoo.co.in9567847444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026